Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Brock

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Investigative Ophthalmology & Visual Science|August 18, 2022
Palpebral Fissure Response to Phenylephrine Indicates Autonomic Dysfunction in Patients With Type 1 Diabetes and PolyneuropathyThomas Arendt Nielsen, Carl Uggerhøj Andersen, Henrik Vorum, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Diabetic Peripheral Neuropathy May Be an Independent Risk Marker for Dementia and Cerebrovascular DiseaseAstrid Wiggers, Vanja Kosjerina, Malin Nilsson, et al.
Diabetologia|January 21, 2017
Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profileAdam D Farmer, Anne Grave Pedersen, Birgitte Brock, et al.
Journal of Patient Safety|March 6, 2015
Medication Review and Patient Outcomes in an Orthopedic Department: A Randomized Controlled StudyMarianne Lisby, Dorthe Krogsgaard Bonnerup, Birgitte Brock, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2012
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemiaMichael Gejl, Lærke Egefjord, Susanne Lerche, et al.
Diabetes, Obesity & Metabolism|July 8, 2026
Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory CytokinesMichelle Damgaard, Marietta Kokla, Rebekka H Gerwig, et al.
Journal of Diabetes and Its Complications|February 9, 2019
Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetesTine Maria Hansen, Birgitte Brock, Anne Juhl, et al.
Frontiers in Neuroenergetics|April 2, 2013
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brainMichael Gejl, Susanne Lerche, Lærke Egefjord, et al.
BMJ Open|October 23, 2025
Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetesMaria Bitsch Poulsen, Tina Okdahl, Jens Hove Buciek, et al.
Neuroscience Research|October 17, 2021
Reduced gray matter brain volume and cortical thickness in adults with type 1 diabetes and neuropathyTine Maria Hansen, Janusiya Anajan Muthulingam, Birgitte Brock, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Investigative Ophthalmology & Visual Science|August 18, 2022
Palpebral Fissure Response to Phenylephrine Indicates Autonomic Dysfunction in Patients With Type 1 Diabetes and PolyneuropathyThomas Arendt Nielsen, Carl Uggerhøj Andersen, Henrik Vorum, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Diabetic Peripheral Neuropathy May Be an Independent Risk Marker for Dementia and Cerebrovascular DiseaseAstrid Wiggers, Vanja Kosjerina, Malin Nilsson, et al.
Diabetologia|January 21, 2017
Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profileAdam D Farmer, Anne Grave Pedersen, Birgitte Brock, et al.
Journal of Patient Safety|March 6, 2015
Medication Review and Patient Outcomes in an Orthopedic Department: A Randomized Controlled StudyMarianne Lisby, Dorthe Krogsgaard Bonnerup, Birgitte Brock, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2012
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemiaMichael Gejl, Lærke Egefjord, Susanne Lerche, et al.
Diabetes, Obesity & Metabolism|July 8, 2026
Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory CytokinesMichelle Damgaard, Marietta Kokla, Rebekka H Gerwig, et al.
Journal of Diabetes and Its Complications|February 9, 2019
Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetesTine Maria Hansen, Birgitte Brock, Anne Juhl, et al.
Frontiers in Neuroenergetics|April 2, 2013
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brainMichael Gejl, Susanne Lerche, Lærke Egefjord, et al.
BMJ Open|October 23, 2025
Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetesMaria Bitsch Poulsen, Tina Okdahl, Jens Hove Buciek, et al.
Neuroscience Research|October 17, 2021
Reduced gray matter brain volume and cortical thickness in adults with type 1 diabetes and neuropathyTine Maria Hansen, Janusiya Anajan Muthulingam, Birgitte Brock, et al.
Pageof 10